1. Home
  2. AVXL vs ACNB Comparison

AVXL vs ACNB Comparison

Compare AVXL & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • ACNB
  • Stock Information
  • Founded
  • AVXL 2004
  • ACNB 1857
  • Country
  • AVXL United States
  • ACNB United States
  • Employees
  • AVXL N/A
  • ACNB N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • ACNB Major Banks
  • Sector
  • AVXL Health Care
  • ACNB Finance
  • Exchange
  • AVXL Nasdaq
  • ACNB Nasdaq
  • Market Cap
  • AVXL 484.2M
  • ACNB 401.0M
  • IPO Year
  • AVXL N/A
  • ACNB N/A
  • Fundamental
  • Price
  • AVXL $7.45
  • ACNB $47.45
  • Analyst Decision
  • AVXL Strong Buy
  • ACNB Buy
  • Analyst Count
  • AVXL 2
  • ACNB 2
  • Target Price
  • AVXL $43.00
  • ACNB $37.00
  • AVG Volume (30 Days)
  • AVXL 1.6M
  • ACNB 17.6K
  • Earning Date
  • AVXL 11-25-2024
  • ACNB 10-24-2024
  • Dividend Yield
  • AVXL N/A
  • ACNB 2.70%
  • EPS Growth
  • AVXL N/A
  • ACNB N/A
  • EPS
  • AVXL N/A
  • ACNB 3.44
  • Revenue
  • AVXL N/A
  • ACNB $106,401,000.00
  • Revenue This Year
  • AVXL N/A
  • ACNB N/A
  • Revenue Next Year
  • AVXL N/A
  • ACNB $20.49
  • P/E Ratio
  • AVXL N/A
  • ACNB $13.80
  • Revenue Growth
  • AVXL N/A
  • ACNB N/A
  • 52 Week Low
  • AVXL $3.25
  • ACNB $30.24
  • 52 Week High
  • AVXL $10.45
  • ACNB $50.72
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 54.68
  • ACNB 59.53
  • Support Level
  • AVXL $7.55
  • ACNB $46.70
  • Resistance Level
  • AVXL $10.45
  • ACNB $49.33
  • Average True Range (ATR)
  • AVXL 0.84
  • ACNB 1.68
  • MACD
  • AVXL 0.08
  • ACNB 0.34
  • Stochastic Oscillator
  • AVXL 37.77
  • ACNB 66.25

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Bank which generates the majority of the revenue provides banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

Share on Social Networks: